Cara Therapeutics Inc (CARA) stock is down -4.9% over the past week. CARA stock has risen 43.76% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CARA stock a score of 59 out of a possible 100.
That score is primarily influenced by a long-term technical score of 71. CARA’s score also includes a short-term technical score of 61. The fundamental score for CARA is 45. In addition to the average rating from Wall Street analysts, CARA stock has a mean target price of $25.63. This means analysts expect the stock to gain 40.82% over the next 12 months.
What’s Happening with CARA Stock Today
Cara Therapeutics Inc (CARA) stock is down -0.16% while the S&P 500 has risen 0.3% as of 11:08 AM on Wednesday, May 15. CARA is down -$0.03 from the previous closing price of $18.23 on volume of 130,435 shares. Over the past year the S&P 500 has risen 4.13% while CARA has risen 43.76%. CARA lost -$2.10 per share in the over the last 12 months.